Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor

Affiliations

• ¹ Pediatric Department, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy [email protected].
• ² Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
• ³ University Medical Center, Christian-Albrechts-University Kiel, Germany.
• ⁴ Pediatric Department, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy.
• ⁵ EsPhALL Trial Data Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
• ⁶ Department of Pediatric Oncology, Skane University Hospital, Lund, Sweden.
• ⁷ CHU Hôpital Sud, Rennes, France.
• ⁸ Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
• ⁹ University Hospital Motol, Department of Pediatric Hematology and Oncology, Prague, Czech Republic.
• ¹⁰ University Medical Center Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.
• ¹¹ Chilean National Pediatric Oncology Group, PINDA, Hospital Roberto del Rio, Santiago, Chile.
• ¹² Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.
• ¹³ The Chinese University of Hong Kong, China.
• ¹⁴ Great Ormond Street Hospital for Children, London, UK.
• ¹⁵ Department of Pediatric Hematology and Oncology, Justus Liebig University, Giessen, Germany.
• ¹⁶ Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK.